Related Experiment Video

Updated: May 31, 2026

Transmitochondrial Cybrid Generation Using Cancer Cell Lines
07:49

Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

Mitochondrial recoupling: a novel therapeutic strategy for cancer?

G Baffy1, Z Derdak, S C Robson

  • 1Department of Medicine, VA Boston Healthcare System and Brigham and Women's Hospital, Harvard Medical School, 150 S Huntington Avenue, Room A6-46, Boston, MA 02130, USA. gbaffy@partners.org

British Journal of Cancer
|June 30, 2011
PubMed

Insights

Mitochondrial uncoupling proteins (UCPs) drive cancer cell metabolism, tumor suppression, and chemoresistance. Inhibiting UCPs offers a novel anti-cancer strategy by disrupting these processes.

Area of Science:

  • Biochemistry
  • Oncology
  • Cell Biology

Background:

  • Cancer cells exhibit altered metabolism, with mitochondrial uncoupling proteins (UCPs) playing a key role.
  • UCPs influence adenosine 5'-triphosphate synthesis and glycolytic pathways.
  • UCPs also affect oxidative stress by suppressing superoxide generation.

Purpose of the Study:

  • To review current evidence on the role of UCPs in cancer.
  • To explore the potential of inhibiting UCPs as an anti-cancer strategy.

Main Methods:

  • Literature review of recent findings on UCPs in cancer metabolism and function.

Main Results:

  • UCPs induce proton leak, impacting ATP synthesis and glycolysis.
  • UCPs suppress superoxide generation, reducing oxidative stress.
  • UCP2 is upregulated in some cancers, promoting metabolic reprogramming, tumor suppression, and chemoresistance.

Conclusions:

  • Inhibiting mitochondrial uncoupling presents a promising novel anti-cancer strategy.
  • Targeting UCPs may overcome metabolic reprogramming and chemoresistance in cancer.

More Related Videos

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity07:58

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity

Published on: May 12, 2020

Assessment of the Metabolic Profile of Primary Leukemia Cells06:21

Assessment of the Metabolic Profile of Primary Leukemia Cells

Published on: November 21, 2018

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...